Join
Live feed
·
PRReleasevia Quantisnow
Vyome Holdings Inc. logo

Vyome to Present Compelling Phase 2 Clinical Data on VT-1953 for Treatment of MFW at AACR 2026

ByQuantisnow·Wall Street's wire, on your screen.
HIND· Vyome Holdings Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HIND (Vyome Holdings Inc.) and more on Quantisnow.